SCHEMBL19255610

SCHEMBL19255610

Cc1ccc(CCc2ccc(N)cc2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 2/20 0.74
ACHE P22303 1/20 0.68
CYP1A2 P05177 1/20 0.68
CYP2A6 P11509 1/20 0.68
TAAR1 Q96RJ0 1/20 0.68
MAOB P27338 4/20 0.61
MAOA P21397 2/20 0.61
TEAD4 Q15561 1/20 0.52
CYP19A1 P11511 5/20 0.52
ALDH1A1 P00352 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 1/20 0.50
CYP3A4 P08684 1/20 0.50
TSHR P16473 1/20 0.50
MEN1 O00255 1/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
KMT2A Q03164 1/20 0.49
KCNH2 Q12809 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8356905 0.90 TAAR1 (0.86) GFERACHECYP1A2CYP2A6TAAR1
SCHEMBL11116695 0.90 CYP1A2 (0.62) GFERACHECYP1A2CYP2A6TAAR1
SCHEMBL11136760 0.88 MAOB (0.74) GFERACHECYP1A2CYP2A6TAAR1
SCHEMBL7902954 0.87 GFER (0.56) GFERACHECYP1A2CYP2A6TAAR1
SCHEMBL3482833 0.86 GFER (1.00) GFERMAOBMAOACYP19A1ALDH1A1
SCHEMBL187043 0.86 GFER (1.00) GFERMAOBMAOACYP19A1ALDH1A1
SCHEMBL8164156 0.86 GFER (1.00) GFERMAOBMAOACYP19A1ALDH1A1
SCHEMBL11288839 0.86 CYP1A2 (0.68) GFERACHECYP1A2CYP2A6TAAR1
SCHEMBL143961 0.86 CYP1A2 (0.68) GFERACHECYP1A2CYP2A6TAAR1
SCHEMBL2923178 0.84 CYP3A4 (0.74) GFERACHECYP1A2CYP2A6TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170233529-A1 BIS(AZOBENZENE) DIAMINES AND PHOTOMECHANICAL POLYMERS MADE THEREFROM GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) 2017-08-17 US disclosed
US-20100273842-A1 AMINE DERIVATIVES HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY AND THE USES THEREOF SHIONOGI & CO., LTD. (JP) 2010-10-28 US disclosed
US-20100267945-A1 AMINE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY SHIONOGI & CO., LTD. (JP) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100273842-A1 AMINE DERIVATIVES HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY AND THE USES THEREOF NPY5R, NPY1R, NPY2R GFER 2187/4885ACHE 2624/4885CYP1A2 1506/4885
US-20100267945-A1 AMINE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY NPY5R, NPY1R, NPY2R GFER 2298/4885ACHE 1393/4885CYP1A2 1378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.